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Abstract
C. canimorsus 5 has the capacity to grow at the expenses of glycan moieties from host cells N-glycoproteins. Here, we show
that C. canimorsus 5 also has the capacity to deglycosylate human IgG and we analyze the deglycosylation mechanism. We
show that deglycosylation is achieved by a large complex spanning the outer membrane and consisting of the Gpd proteins
and sialidase SiaC. GpdD, -G, -E and -F are surface-exposed outer membrane lipoproteins. GpdDEF could contribute to the
binding of glycoproteins at the bacterial surface while GpdG is a endo-b-N-acetylglucosaminidase cleaving the N-linked
oligosaccharide after the first N-linked GlcNAc residue. GpdC, resembling a TonB-dependent OM transporter is presumed to
import the oligosaccharide into the periplasm after its cleavage from the glycoprotein. The terminal sialic acid residue of the
oligosaccharide is then removed by SiaC, a periplasm-exposed lipoprotein in direct contact with GpdC. Finally, most likely
degradation of the oligosaccharide proceeds sequentially from the desialylated non reducing end by the action of
periplasmic exoglycosidases, including b-galactosidases, b-N-Acetylhexosaminidases and a-mannosidases.
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Introduction
Capnocytophaga are capnophilic Gram negative bacteria that
belong to the family of Flavobacteriaceae in the phylum Bacteroidetes
and colonize the oral cavity of diverse mammals including humans
[1,2]. Capnocytophaga canimorsus, a usual member of dog’s mouths
flora [3,4], was discovered in 1976 [5] in patients that underwent
dramatic infections after having been bitten, scratched or simply
licked by a dog. These infections occur, worldwide, with an
approximate frequency of one per million inhabitants per year.
They generally begin with flu symptoms and evolve in a few days
into fulminant septicaemia and peripheral gangrene with a
mortality as high as 40% [5,6,7,8,9]. A few recent observations
help understanding the high aggressiveness of C. canimorsus for
humans. First, C. canimorsus are able to escape complement killing
and phagocytosis by human polymorphonuclear leukocytes
(PMN’s) [10,11]. They also escape detection and phagocytosis
by macrophages, which results in a lack of release of pro-
inflammatory cytokines [12]. In addition to this passive evasion
from innate immunity, 60% of the strains are able to block the
killing of Escherichia coli phagocytosed by macrophages [3,10] and
some strains even block the onset of pro-inflammatory signalling
induced by an E. coli lipopolysaccharide (LPS) stimulus [12]. The
molecular bases of these immunosuppressive mechanisms are not
understood yet. However, their study led to the serendipitous
discovery that the fastidious C. canimorsus grow readily upon direct
contact with mammalian cells including phagocytes. This property
was found to be dependent on a sialidase (SiaC) allowing C.
canimorsus to harvest amino sugars of glycan chains from host cell
glycoproteins [13]. Recently, we reported the complete 2,571,405-
bp genome sequence and the surface proteome of strain Cc5
(Manfredi et al., submitted). Among others, this study unravelled
the existence of 13 complex feeding systems encoded by
polysaccharide utilization loci (PULs), a hallmark of the Cyto-
phaga-Flavobacteria-Bacteroides (CFB) group [14,15]. The archetype
of these systems is the Sus system, pioneered by the laboratory of
A. Salyers and allowing Bacteroides thetaiotaomicron to forage starch.
It is composed of the surface-exposed SusCDEF protein complex
[15,16] and the SusAB periplasmic proteins [17]. SusC resembles
a TonB-dependent transporter essential for energy-dependent
import of starch oligosaccharides into the periplasm [18] while
SusD is a a-helical starch-binding lipoprotein [19,20]. SusE and
SusF are other surface-exposed lipoproteins that reinforce starch
binding [17]. Finally, the outer membrane a-amylase SusG
hydrolyses surface-bound starch [19]. B. thetaiotaomicron has 88 of
these PULs, identified essentially by the presence of a pair of
adjacent susC-like and susD-like alleles. Interestingly, expression of
some PULs is upregulated in the presence of mucin O-glycans or
glycosaminoglycans (GAGs), indicating that B. thetaiotaomicron also
forages on host glycans, primarily the O-glycosylated mucin [14]
but these glycoprotein foraging systems have not been character-
ized so far. Although Streptococcus oralis, a firmicute from the human
oral flora and S. pneumoniae have been shown to remove and
metabolize N-linked complex glycans of human glycoproteins
[21,22,23], no Sus-like-N-linked glycan foraging system has been
described in detail. One of the 13 Sus-like systems from C.
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and to deglycosylate glycoproteins. It is encoded by chromosome
locus PUL5 and accounts for 12% of the Cc5 surface proteins.
Since it contributes to survival in mice. it can be seen as a new type
of bacterial virulence factor (Manfredi et al., submitted). Here, we
present a detailed molecular characterization of this PUL5-
encoded foraging complex and we show that it deglycosylates
human immunoglobulins G (IgG). Among others, we show that it
cleaves N-linked glycan moieties between two GlcNAc residues
and we show its functional relation with sialidase.
Results
Genetic analysis of the PUL5 locus
PUL5 consists of the five genes Ccan_08700–Ccan_08740.
Ccan_08700 encodes a SusC-like integral outer membrane (OM)
protein presumably forming a pore in the OM while Ccan_08710 is
a SusD-like protein presumably involved in substrate binding [20].
Since the locus was shown to confer the capacity to deglycosylate
proteins (Manfredi et al., submitted), we named the five genes gpd
(for glycoprotein deglycosylation) and we called gpdC and gpdD the
genes encoding homologs to SusC and SusD, respectively. The
five gpd genes seem to be organized as an operon in the order gpdC,
gpdD, gpdG, gpdE and gpdF (Fig. 1A). GpdG is predicted to be an
endo-b-N-acetylglucosaminidase and GpdE has similarities with
the Concanavalin A-like lectins/glucanases superfamily on its 108
C-terminal amino acids and could have a substrate-binding role
analogous to that of GpdD. Finally, GpdF shows homology to the
galactose-binding domain-like superfamily on its 136 C-terminal
amino acids suggesting again a role in glycan binding.
In order to investigate what is the function of the individual Gpd
proteins we constructed single gpd genes knockout strains. None of
the knockout mutants was significantly affected in its growth on
blood agar plates. In contrast, deletion of any of the gpdC, -D, -G or
-E genes led to a clear reduction of growth on HEK293 cells while
deletion of gpdF had only a slight effect (Fig. 1B). Complemen-
tation of the deleted genes with plasmid-borne genes expressed
from the natural gpdC promoter completely restored growth to the
wildtype (wt) level indicating that none of the mutation was polar.
In order to determine whether the reduced growth of the
mutants was due to a defect in protein deglycosylation, we
incubated wt Cc5 bacteria and the gpd mutant bacteria with fetal
calf serum protein fetuin, taken as a standard glycoprotein. Fetuin
contains 3 O-linked glycans (accounting for 20% of fetuin-bond
carbohydrates) and 3 N-linked glycans (80% of fetuin-bond
carbohydrates) [24]. We monitored glycosylation by staining with
Sambucus nigra agglutinin (SNA), a lectin that recognizes terminal
sialic acids on glycans. As shown in Fig. 1C, fetuin that had been
incubated with wt Cc5 reacted much less with SNA and appeared
as two, still sialylated smaller degradation products. As shown by
Manfredi et al. (submitted), this indicated that partial deglycosyla-
tion had occurred and progressed further than a simple
desialylation. In contrast, fetuin that was incubated with the gpdC,
-D, -G and -E mutant bacteria was unaffected, indicating that no
desialylation occurred in the absence of these gpd genes, although
sialidase SiaC [13] was not directly affected. Fetuin incubated with
the gpdF mutant showed a slight desialylation indicating that fetuin
deglycosylation was not completely abolished as with the other
mutants. Fetuin glycosylation was also monitored by immuno-
blotting with anti-fetuin antibodies. As shown in Fig. 1D, the size
of fetuin was shifted down after incubation with wt Cc5 bacteria
while the protein migration rate was unchanged after incubation
with the gpdC, -D, -G and -E mutant bacteria. After incubation
with gpdF mutant bacteria, fetuin did undergo a size shift but not as
marked as when incubated with wt bacteria. Taken together these
results indicate that partial fetuin deglycosylation was strictly
dependent on the activity of proteins GpdC, -D, -G, -E and, to a
lesser extend -F. Finally, our data strongly suggest that the defect
in growth of the gpd mutants onto HEK293 cells was due to a
defect in the ability to deglycosylate host glycoproteins.
GpdG is an endo-b-N-acetylglucosaminidase
GpdG is annotated as an endo-b-N-acetylglucosaminidase
(Manfredi et al., submitted), i.e an endo-glycosidase that cleaves
N-linked glycan structures at the base of the glycan in between two
GlcNAc molecules. Hence, it should leave one GlcNac molecule
attached to the protein. Fetuin is reported to be glycosylated on
the three asparagine residues N99, N156 and N176 [24]. Analysis
by liquid chromatography-mass spectrometry (LC-MS) of trypsin-
digested fetuin showed that the main glycosylation site resides on
N156. The m/z is in accordance with the peptide
LCPDCPLLAPLNDSR carrying the GlcNAc5Man3Gal3Sial3
sugar (Fig. 2A). N176 was found to carry a sugar with a
Hex6HexNAc5NeuAc4 composition, but its site occupancy was
much lower than N156. Only trace amounts of glycans were found
attached to N99. After incubation of fetuin with wt Cc5 bacteria,
LC-MS analysis revealed the presence of a peptide whose mass
indicated that only one GlcNAc moiety remained linked to N156
(Fig. 2B). The fragmentation spectrum of this peptide fully
confirmed the presence of the GlcNAc moiety on N156 (Fig. 2C).
Due to the low site occupancy of N176, deglycosylation of N176 to
the GlcNAc moiety was too weak to be detected. The conversion
of GlcNAc5Man3Gal3Sial3 to GlcNAc on N156 suggests an endo-
b-N-acetylglucosaminidase dependent deglycosylation.
To confirm that fetuin deglycosylation was due to the Gpd
complex activity and in particular to the GpdG glycosyl hydrolase
activity, we then analysed fetuin after incubation with the gpdG
knockout bacteria. Fetuin incubated in the presence of these
mutant bacteria turned out to remain fully glycosylated (Fig. 2D)
indicating that no cleavage occurred in the absence of the enzyme.
The sequence of GpdG was then compared to those of two
endo-b-N-acetylglucosaminidases, namely EndoS from Streptococcus
pyogenes capable of deglycosylating N-linked glycans from the c
chain of human immunoglobulins [25], and EndoF from
Flavobacterium meningosepticum capable of cleaving off high-mannose
and complex glycan N-linked from several glycoproteins including
immunoglobulins [26]. It appeared that a chitinase motif present
Author Summary
Capnocytophaga canimorsus are Gram-negative bacteria
from the normal oral flora of dogs and cats. They cause
rare but severe infections in humans that have been bitten
or simply licked by a dog or cat. Fulminant septicemia and
peripheral gangrene with a high mortality are the most
common symptoms. A surprising feature of these bacteria
is their capacity to feed by foraging the glycan moieties of
glycoproteins from animal cells, including phagocytes.
Here we show that C. canimorsus can also deglycosylate
human IgGs reinforcing the idea that this property of
harvesting host glycoproteins may contribute to patho-
genesis. We also unravel the complete deglycosylation
system which belongs to a large family of systems devoted
to foraging complex glycans, found exclusively in the
Capnocytophaga-Flavobacteria-Bacteroides group, and
whose archetype is the starch harvesting system Sus. It is
the first system devoted to deglycosylation of glycopro-
teins to be characterized.
N-linked Glycoprotein Deglycosylation Complex
PLoS Pathogens | www.plospathogens.org 2 June 2011 | Volume 7 | Issue 6 | e1002118Figure 1. Genetic analysis of the PUL5 locus. (A). Schematic representation of the PUL5 putative operon (top: new gene designation; below:
gene codes derived from the annotation of the genome (Manfredi et al. submitted). (B). Growth of the various individual gpd knockout (black) and
complemented (grey) mutants on HEK293 cells (moi=0.2; 23 hours growth). (C). Glycosylation state of fetuin samples incubated for 2 hours in the
presence of the different strains, monitored by staining with SNA that recognizes terminal sialic acid (2–6) linked to Gal or to GalNAc. (D). Western
blot analysis with anti-fetuin antibodies of fetuin samples incubated as in (C).
doi:10.1371/journal.ppat.1002118.g001
N-linked Glycoprotein Deglycosylation Complex
PLoS Pathogens | www.plospathogens.org 3 June 2011 | Volume 7 | Issue 6 | e1002118in these two enzymes was conserved in GpdG (FDGFDIDWE). In
order to further confirm the endo-b-N-acetylglucosaminidase
activity of GpdG we substituted the essential E205 residue [26]
with a glycine and tested the growth on HEK293 cells of the gpdG
mutant strain expressing in trans the GpdG catalytic mutant. As
shown in Fig. 3A, the GpdG catalytic mutant was impaired in
growth. We then tested the fetuin deglycosylation ability of the
GpdG catalytic mutant. As shown by the lectin staining in Fig. 3B
and by the immuno-blotting in Fig. 3C, bacteria endowed with
the GpdG catalytic mutant were completely impaired in fetuin
Figure 2. LC-MS analysis reveals an endo-b-N-acetylglucosaminidase activity of GpdG. Glycosylation analysis of fetal calf serum fetuin. (A)
N156 glycosylation of untreated bovine fetuin. Selected ion chromatogram for the quadruply charged tryptic peptide whose m/z is in accordance
with a GlcNAc5Man3Gal3Sial3 glycosyl moiety on the LCPDCPLLAPLNDSR peptide. The inset shows the isotope pattern for the N156 glycopeptide. The
blue squares represent GlcNAc, the red and green circles Man and Gal, respectively, and the orange diamonds Sial. (B) Selected ion chromatogram for
the doubly charged N156 GlcNAc-modified LCPDCPLLAPLNDSR glycopeptide of fetuin that had been incubated with wild-type Cc5. The sugar
moieties are designated as in (A). (C) Fragmentation spectrum of the N156- GlcNAc species with the y- and b-ions that conclusively show the GlcNAc
modification of N156. (D) N156 glycosylation of bovine fetuin that had been treated with the DgpdG strain. Selected ion chromatogram for the
quadruply charged tryptic peptide carrying the presumed GlcNAc5Man3Gal3Sial3 glycosyl moiety on the LCPDCPLLAPLNDSR peptide. The inset shows
the isotope pattern for the N156 glycopeptide. The sugar moieties are designated as in (A).
doi:10.1371/journal.ppat.1002118.g002
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GpdG is an endo-b-N-acetylglucosaminidase.
The Gpd complex deglycosylates human IgG
Since GpdG has the same chitinase motif as EndoF and EndoS,
known to deglycosylate N-linked glycans from the c chain of
human IgGs [25,26], we tested whether the Gpd complex would
also be able to deglycosylate the heavy chain of IgGs. Cleavage of
the N297-linked glycan moiety by EndoS was shown to determine
a sizeshiftof,3 KDa[25].Afterincubationofpurified humanIgG
withwt Cc5bacteria, the molecular mass of the c chain underwent a
slight size shift (Fig. 4A and B) while the mass of the light chains
was unchanged (Fig. 4A). In contrast incubation with DgpdG
knockout bacteria did not alter the c chain size indicating that the
cleavage was GpdG dependent. To confirm that the size reduction
of the c chain was due to the removal of the glycan moiety, IgG was
stained with SNA. As shown in Fig. 4C, the SNA signal of the c
chain was significantly reduced after incubation with wt Cc5.I n
contrast the c chains remained fully glycosylated after incubation
with DgpdG bacteria. Analysis by LC-MS of trypsin-digested IgG
showed that N297 from this sample of IgG mainly bears a
GlcNAc4Man3Gal2Sial1Fuc1 chain or a GlcNAc4Man3Gal2Fuc1
chain (Fig. 5A–B). After incubation of this sample of IgG with wt
Cc5 bacteria, LC-MS analysis revealed the presence of a peptide
whose mass indicated that only a GlcNAc1Fuc1 moiety remained
linked to N297 (Fig. 5C). The fragmentation spectrum of this
peptide fully confirmed the presence of the GlcNAc1Fuc1 moiety on
N297 (Fig. 5D). LC-MS analysis of IgG after incubation with
DgpdG bacteria revealed exactly the same profile as in the untreated
sample indicating that no deglycosylationhas occurred (Fig. 5E–F).
The conversion of GlcNAc4Man3Gal2Sial1Fuc1 and GlcNAc4-
Man3Gal2Fuc1 to GlcNAc1Fuc1 on N297 indicates an endo-b-N-
acetylglucosaminidase (GpdG) dependent deglycosylation. These
data indicated that, like F. meningosepticum and S. pyogenes, C.
canimorsus has the capacity to deglycosylate IgGs.
GpdD, -G, -E and -F are lipoproteins and lipid
modification is fundamental for the complex activity
The GpdD, -G, -E and –F proteins belong to the OM and
surface proteomes of Cc5 (Manfredi et al., submitted). In addition,
these proteins are endowed with a signal peptidase II consensus
signal peptide. Altogether, this suggests that they could be
lipoproteins anchored to the outer leaflet of the outer membrane
and exposed at the surface of the bacterium (Manfredi et al.,
submitted). In order to determine whether the lipidation of the
Gpd proteins is required for their function, we generated soluble
periplasmic versions of GpdD and GpdG by substituting the
cystein residue of the lipobox with a glycine. We then tested the
ability of the periplasmic variants of GpdD and GpdG to
complement the growth deficiency of the gpdD and gpdG knockout
strains on HEK293 cells. As shown in Fig. 6, both the GpdD and
GpdG periplasmic variant were unable to complement the growth
deficiency indicating that lipid modification is necessary for the
proper localization and function of the proteins. This conclusion
was reinforced by the fact that bacteria endowed with periplasmic
GpdD or GpdG were unable to deglycosylate fetuin (Fig. 6).
Hence, we infer that GpdD and GpdG are lipoproteins that are
anchored in the outer leaflet of the outer membrane and exposed
to the bacterial surface. The same presumably applies to GpdE
and GpdF since they have also a lipobox and they are also part of
the surface proteome (Manfredi et al., submitted).
The Gpd proteins form a deglycosylation complex
associated with sialidase
In order to assay whether the five Gpd proteins interact with
each other to form a complex at the bacterial surface, we
Figure 4. Human IgG deglycosylation. Glycosylation state of
human IgG samples incubated for 3 hours in the presence of wt and
DgpdG bacteria monitored by Coomassie staining (A), western blot
analysis with anti-IgG antibodies (B) and staining with SNA (C).
doi:10.1371/journal.ppat.1002118.g004
Figure 3. The F197DGFDIDWE205 chitinase motif of GpdG is the catalytic site. E205 from GpdG was substituted with a glycine. (A): Number of
divisions after 23 h growth on HEK293 cells of the DgpdG mutant complemented with gpdG* encoding the catalytic mutant. (B): Fetuin glycosylation
state of samples incubated for 3 hours in the presence of the different strains, determined by staining with the Sambucus nigra lectin (SNA) that
recognizes terminal sialic acid (2–6) linked to Gal or to GalNAc. (C): same as B after western blot analysis with anti-fetuin antibodies.
doi:10.1371/journal.ppat.1002118.g003
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PLoS Pathogens | www.plospathogens.org 6 June 2011 | Volume 7 | Issue 6 | e1002118Figure 5. LC-MS analysis of IgG. Glycosylation analysis of human IgG. (A) N297 glycosylation of untreated human IgG. Selected ion chromatogram
for the triply charged tryptic peptide whose m/z is in accordance with a GlcNAc4Man3Fuc1Gal2Sial1 glycosyl moiety on the EEQYNSTYR peptide. The
inset shows the isotope pattern for the N297 glycopeptide. The blue squares represent GlcNAc, the red and green circles Man and Gal, respectively,
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version of GpdC. Analysis by immuno-blot and mass spectrometry
(Fig. 7) of the purified fraction revealed the presence, together
with GpdC, of GpdD, -G, -E and –F, indicating a stable
interaction between all these proteins. Furthermore, six other
proteins, among which SiaC (Fig. 7), co-purified with the
complex.
Sialidase is a periplasmic lipoprotein that interacts with
GpdC
SiaC has been previously shown [13] to be essential to sustain
growth of Cc5 in the presence of eukaryotic cells due to its role in
the glycoprotein deglycosylation process. We thus focused our
attention on the sialidase-Gpd complex interaction. The co-
purification of SiaC with GpdC strongly suggested that SiaC is
associated to the Gpd complex, although it is encoded far away
from PUL5. However, unlike the Gpd proteins, sialidase was not
identified in the surface proteome of Cc5 (Manfredi et al.,
submitted). On the other hand, earlier immunofluorescence assays
suggested that sialidase is localized on the bacterial surface and
removal of the signal sequence of sialidase prevented growth on
cells [13]. In order to better understand the interplay between
SiaC and Gpd proteins in the glycoprotein deglycosylation
process, we decided to clarify its localization.
Since the sialidase sequence analysis revealed the presence of a
signal peptide with a lipobox in the N-terminal sequence, we first
sought to determine whether SiaC is a lipoprotein. We incubated
Cc5 and sialidase mutant (siaC) bacteria encoding SiaCC17Y in the
presence of tritiated palmitate and analyzed the total proteins by
SDS-PAGE and fluorography (Fig. 8A). Sialidase appeared
indeed to be lipidated and the C17Y mutation completely
prevented this lipid modification. The analysis of outer membrane
proteins isolated by sarcosyl extraction confirmed that sialidase but
not its C17Y variant was associated with the OM (Fig. 8B). We
conclude from these experiments that SiaC is a lipoprotein
anchored into the outer membrane.
In order to define whether it is exposed towards the outside like
GpdDGEF or towards the periplasm, we tested whether the
periplasmic SiaC17Y could restore the growth deficiency of the siaC
mutant strain. In contrast to what was observed for GpdD and
GpdG, expression of SiaC17Y in trans did fully restore the growth
defect (Fig. 8C) indicating that the localization of sialidase in the
periplasm and the absence of association with the outer membrane
did not prevent its function. This data pointed to the direction of a
periplasmic localization of SiaC rather than a surface-exposed
localization as was previously suggested [13].
The association between sialidase and the Gpd complex
obviously suggests that the two work cooperatively. This was
already suggested by the fact that the gpd mutant bacteria did not
remove the terminal sialic acid residues from fetuin, although SiaC
was functional in these mutants (Fig. 1C). We then tested the
ability of the siaC knockout bacteria to deglycosylate fetuin. SNA
lectin staining (Fig. 8D) and immuno-blotting (Fig. 8E) clearly
showed the same fetuin deglycosylation pattern for the wt and siaC
mutant bacteria. These results indicate that the endo-cleavage of
fetuin N-glycans, operated by the Gpd complex is completely
independent from the activity of SiaC. However, the evidence that
SiaC activity is essential for growth on Hek293 cells (Fig. 8C),
suggests that removal of the glycan terminal sialic acid is
nevertheless a crucial step for the subsequent glycan catabolism
process. This indicates that the Gpd complex acts upstream of
SiaC. Since the Gpd complex includes the GpdC porin-like
protein, this sequential order is perfectly compatible with a
periplasmic localization of sialidase. Sialic acid removal would thus
occur in the periplasm after the glycan has been cleaved off and
transported through the GpdC OM channel.
If this model was correct, the interaction between the
periplasmic SiaC and the GpdC complex could only occur
through a direct interaction with GpdC, since the other Gpd
proteins are surface exposed. To test this prediction, we expressed
a C-terminally Strep-His double tagged GpdC in a gpdCDGE multi
knockout strain and we performed a two-step affinity purification
of GpdC. The analysis by immuno-blotting (Fig. 8F) of the
fractions eluted after the second purification step showed that SiaC
did indeed co-purify with GpdC indicating that SiaC and GpdC
do indeed interact directly with each other. The complete
deglycosylation complex would thus consist of the surface-exposed
lipoproteins GpdDGEF and the periplasm-exposed lipoprotein
SiaC, all of them associated to the porin-like GpdC (Fig. 8).
Discussion
Our previous work has shown that C. canimorsus deglycosylates
surface glycoproteins from the host and sustains its growth on the
glycan moieties [13]. Here, we showed that this deglycosylating
activity is achieved by the joined action of the PUL5-encoded Gpd
complex and sialidase [13]. PUL5 consists of the five gpdCDGEF
genes. GpdC, an homolog of the archetypal SusC [17], likely
represents the specific OM porin of the system. GpdD is an
homolog of SusD, a starch-binding protein [16,20] and hence
most likely a glycoprotein-binding protein. On the basis of their
annotation, we propose that GpdE and GpdF are also glycan-
binding proteins. GpdG was annotated as an endo-b-N-acetylglu-
cosaminidase (Manfredi et al., submitted) and this annotation was
shown to be correct. Indeed mass spectrometry analyses
demonstrated that GpdG deglycosylates the tribranched GlcNAc5-
Man3Gal3Sial3 glycan structure linked to N156 from the model
glycoprotein fetuin, leaving one GlcNac residue on the protein.
GpdDGEF were predicted to be lipoproteins (Manfredi et al.,
submitted). Replacement of the critical cysteine of the lipoprotein
signal peptide from GpdD and GpdG completely abolished the
deglycosylating activity, indicating that a periplasmic location did
not sustain the activity. These data, together with the fact that the
two proteins belong to the surface proteome indicate that these
two lipoproteins are exposed to the surface and not to the
periplasm. We assume the same is true for GpdE and F since, like
the orange diamonds Sial, and triangle Fuc. (B) N297 glycosylation of untreated human IgG. Selected ion chromatogram for the triply charged tryptic
peptide whose m/z is in accordance with the GlcNAc4Man3Fuc1Gal2 glycosyl moiety on the EEQYNSTYR peptide. The inset shows the isotope pattern
for the N297 glycopeptide. The sugar moieties are designated as in (A). (C) Selected ion chromatogram for the doubly charged N297 GlcNAc1Fuc1-
modified glycopeptide of IgG that had been incubated with wild-type Cc5. The sugar moieties are designated as in (A). (D) Fragmentation spectrum
of the N297 GlcNAc1Fuc1 species with the y- and b-ions that conclusively show the GlcNAc1Fuc1 modification of N297. (E) N297 glycosylation of
human IgG that had been treated with the DgpdG strain: selected ion chromatogram for the triply charged tryptic peptide carrying the presumed
GlcNAc4Man3Fuc1Gal2Sial1 glycosyl moiety on the EEQYNSTYR peptide. The inset shows the isotope pattern for the N297 glycopeptide. For the sugar
structure see (A). (F) N297 glycosylation of human IgG that had been treated with the DgpdG strain: selected ion chromatogram for the triply charged
tryptic peptide carrying the presumed GlcNAc4Man3Fuc1Gal2 glycosyl moiety on the EEQYNSTYR peptide. The inset shows the isotope pattern for the
N297 glycopeptide. For the sugar structure see (A).
doi:10.1371/journal.ppat.1002118.g005
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and they belong to the surface proteome. Interestingly, all the five
Gpd proteins could be co-purified with the porin-like GpdC,
indicating that they all form one single complex at the bacterial
surface. Unexpectedly, not only GpdD, -G, -E and -F co-purified
with GpdC but also SiaC. Although SiaC was known to be part of
the catabolic process, SiaC is not encoded together with
GpdCDGEF (Manfredi et al., submitted) and it was not anticipated
that the interaction would be so close. SiaC turned out to be also a
lipoprotein but, unlike GpdD and GpdG, it was still functional
when it was directed to the periplasm, unlipidated. We inferred
from this observation that, contrary to our initial report, SiaC is a
periplasm-oriented lipoprotein. Thus, the observations presented
here suggest the model illustrated in Fig. 9: The surface-exposed
GpdCDEF complex captures the N-linked complex glycan
moieties of glycoproteins, which are then detached from the
protein by GpdG and internalized by GpdC. As soon as they
reach the periplasm, SiaC removes the terminal sialic acid. This
sequence of events is strongly supported by the observation that
gpd mutant bacteria do not desialylate fetuin, although SiaC is
functional in these mutants (Fig. 1). After desialylation, the
oligosaccharide would be sequentially degraded by periplasmic
Figure 6. Lipid modification of GpdD and GpdG is essential for their activity. (A) Number of divisions after 23 h growth on HEK293 cells of
the DgpdG bacteria complemented with gpdDC17G and gpdGC21G. (B) Fetuin glycosylation state of samples incubated for 2 hours in the presence of
the different strains, determined by staining with SNA. (C) Same as B analyzed by western blot with anti-fetuin antibodies.
doi:10.1371/journal.ppat.1002118.g006
Figure 7. Gpd proteins form a complex with sialidase. Streptavidine affinity purification of GpdC-His-Strep expressed from its natural promoter
in a DgpdC background. (A) Detection by western blot of GpdC (anti-His antibody), GpdG (anti-GpdG) and Sialidase (anti-SiaC) in the elution fractions.
(B) List of protein identified by Mass spectrometry in the elution fractions.
doi:10.1371/journal.ppat.1002118.g007
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3H-palmitate labeled sialidase in different bacteria. (B)
Detection of sialidase by western blot analysis (anti-SiaC antibody) in total cell extracts (TC) and outer membrane protein (OMP) fractions of Cc5 wt
and DsiaC bacteria complemented with the soluble periplasmic sialidase (SiaCC17Y). (C) Number of divisions after 23 hours growth on HEK293 cells of
DsiaC bacteria expressing SiaC or SiaCC17Y. (D) Fetuin glycosylation state after 2 hours of incubation in the presence of the different strains,
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the cytosol. This last step of the model is supported by the fact that
the genome encodes three putative b-galactosidases (Ccan_01530,
Ccan_15520, Ccan_17480), five putative b-N-acetylhexosamini-
dases (Ccan_03860, Ccan_04040, Ccan_16820, Ccan_17870,
Ccan_20090) and four putative a-mannosidases (Ccan_00510,
Ccan_01900, Ccan_04050 and Ccan_16220), all of them endowed
with a signal peptide I or II, and none of them surface exposed
(Manfredi et al., submitted). The b-galactosidase and a-mannosi-
dase activities were confirmed in the crude extract (data not
shown). The three b-galactosidases seemed actually redundant
since they could all be individually knocked out without affecting
the growth on cells (data not shown).
This global model strikingly reminds the archetypal Sus system
shown to consist of one single complex made of SusCDEF [16]. It
is thought that SusG, an endo-acting enzyme, generates internal
cuts in a bound starch molecule and releases oligosaccharides
larger than maltotriose, which are then transported by SusC into
the periplasmic compartment. In the periplasm, glycoside
hydrolases SusA and SusB then degrade the oligosaccharides into
their component sugars prior to final transport to the cytosol
[27,28]. The two systems are thus remarkably conserved, although
they adapted to different complex saccharides.
To our knowledge, the Gpd system is the first Sus-like system
devoted to foraging N-linked glycoproteins. It contributes to
sustain growth of C. canimorsus at the expenses of cultured cells
(Manfredi et al., submitted). Since C. canimorsus has 13 PULs
(Manfredi et al., submitted), it is very likely that some of them could
be devoted to the harvest of O-linked glycans, but this activity has
not been identified thus far. The best approach would probably be
to look for upregulation in the presence of O-linked glycoproteins,
as was done in B. thetaiotaomicron [29]. Deglycosylation of N-linked
glycans is not unprecedented among pathogens and commensals.
As mentioned earlier, two streptococci, S. pyogenes and S. oralis have
this remarkable property. In the case of S. pyogenes, this activity is
exerted towards IgGs by secreted endoglycosidase EndoS and it
does not seem to play a major role in nutrient acquisition [25]. In
contrast, in S. oralis, the activity was shown to sustain growth [30].
It is interesting to notice that S. oralis, like C. canimorsus, is emerging
as an important opportunistic pathogen originating from the oral
flora. This commonality between two very different bacteria from
the same ecosystem suggests first that the capacity to deglycosylate
host proteins is a favourable trait in the mouth ecosystem and,
second, could favour opportunistic infections. Deglycosylation of
IgGs is very likely to contribute to a generalized infection as
discussed by Collin and Olsen [25] but, for C. canimorsus, one
cannot exclude that deglycosylation of other host proteins would
also significantly contribute to pathogenesis.
Our data demonstrate that PUL-encoded lipoproteins are
surface-exposed. Prolipoproteins are exported through the Sec
Figure 9. Functional model of complex N-linked glycan moieties deglycosylation processing by C. canimorsus. Individual glycan
processing steps are illustrated. (A) The glycan moiety is bound at the bacterial surface by the Gpd complex. (B) The glycan mopiety is endo-cleaved
by GpdG and imported into the periplasm trough the GpdC pore. (C) Terminal sialic acid is cleaved by sialidase (SiaC). (D) The glycan is further
processed by the sequencial activity of several periplasmic exoglycosidases.
doi:10.1371/journal.ppat.1002118.g009
determined by staining SNA. (E) Same as D, analyzed by western blot with anti-fetuin antibodies. (F) Co-purification of SiaC with GpdC-Strep-His
produced in a DgpdCDGE background. GpdC was detected with anti-Strep antibody and SiaC with anti-SiaC antibodies.
doi:10.1371/journal.ppat.1002118.g008
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membrane (IM) by the sequential action of glyceryl transferase, O-
acyl transferase(s) and prolipoprotein signal peptidase (signal
peptidase II). A mature lipoprotein harbours as a first aminoacid
a cysteine residue that is lipid modified with a N-Acyl diacyl
Glyceryl group which serves to anchor the protein to the IM. In
Gram-negative bacteria some lipoproteins are destined for the
OM. These proteins are extracted from the IM, transported across
the periplasm and inserted in the inner leaflet of the OM by the
Lol pathway (for review see refs [31,32]. Insertion of lipoproteins
into the outer leaflet of the OM is however established in some
pathogens like Borrelia but the pathway is neither well documented
nor well understood [32]. Since bacteria from the Cytophaga-
Flavobacteria-Bacteroides group massively insert lipoproteins in the
outer leaflet of the OM, we postulate that they have an original
system dedicated to the transport of lipoproteins across the OM
but this system still needs to be identified and investigated.
Materials and Methods
Bacterial strains and growth conditions
Conventional bacterial growth conditions and selective
agents. The strains used in this study are listed in Table 1.
Escherichia coli strains were routinely grown in LB broth at 37uC. C.
canimorsus bacteria were routinely grown on heart infusion agar
(Difco) supplemented with 5% sheep blood (Oxoid) for 2 days at
37uC in the presence of 5% CO2. To select for plasmids,
antibiotics were added at the following concentrations: 10 mg/ml
erythromycin (Em), 10 mg/ml cefoxitin (Cf), 20 mg/ml gentamicin
(Gm), 100 mg/ml ampicillin (Ap) and 50 mg/ml kanamycin (Km).
Growth of Cc5 bacteria on HEK293 cultured
cells. Human Embryonic Kidney 293 cells (HEK293) were
cultured in DMEM (Invitrogen) with 10% (v/v) fetal calf serum
(Invitrogen) and 1 mM sodium pyruvate. Cells were grown in
medium without antibiotics in a humidified atmosphere enriched
with 5% CO2 at 37uC. Bacteria were harvested by gently scraping
colonies off the agar surface and resuspended in PBS. A total of
4610
4 bacteria were incubated with 2610
5 HEK293 cells
(MOI=0.2) in a final volume of 1 ml medium devoid of
antibiotics for 23 h.
Mutagenesis and allelic exchange
Mutagenesis of Cc5 wt has been performed has described in ref
[33] with slight modifications. Briefly, replacement cassettes with
flanking regions spanning approximately 500 bp homologous to
direct gpd framing regions were constructed with a three-fragment
overlapping-PCR strategy. First, two PCRs were performed on
100 ng of of Cc5 genomic DNA with primers A and B (Table 2)
for the upstream flanking regions and with primers C and D for
the downstream regions. Primers B and C contained an additional
59 20-nucleotide extension homologous to the resistance ermF
insertion cassette. The ermF resistance cassette was amplified from
plasmid pMM106 DNA with primers 5502 and 5503. All three
PCR products were cleaned and then mixed in equal amounts for
PCR using Phusion polymerase (Finnzymes). The initial denatur-
ation was at 98uC for 2 min, followed by 12 cycles without primers
to allow annealing and elongation of the overlapping fragments
(98uC for 30 s, 50uC for 40 s, and 72uC for 2 min). After the
addition of external primers (A and D), the program was
continued with 20 cycles (98uC for 30 s, 50uC for 40 s, and
72uC for 2 min 30 s) and finally 10 min at 72uC. Final PCR
products consisted in gpd::ermF insertion cassettes and were then
digested with PstI and SpeI for cloning into the appropriate sites of
the C. canimorsus suicide vector pMM25. Resulting plasmids were
transferred by RP4-mediated conjugative DNA transfer from E.
coli S17-1 to C. canimorsus 5 to allow integration of the insertion
cassette. Transconjugants were then selected for presence of the
ermF cassette, checked for sensitivity to cefoxitin and the deleted
regions were sequenced.
Construction of complementation and expression
plasmids
Plasmid pPM1, used for complementation and expression of the
Gpd proteins, is a derivative of the E. coli- C. canimorsus shuttle vector
pMM47A.1 [33]. pMM47A.1 ermF promoter region was cleaved
with SalIa n dNcoI and the 117 nucteotides upstream the gpdC
starting codon sequence, containing the putative gpdC promoter,
was cloned using the same restriction sites. Full length gpdC,- D,- G,-
E and -F were amplified with the specific primers listed in Table 3
and cloned into plasmid pPM1 into NcoI and XbaI restriction sites
leading to the insertion of a glycine at position 2.
The E205G substitution inactivating the catalytic site of GpdG
was introduced by site directed mutagenesis by overlapping PCR
using primers 5008/6061 and 6060/6055 and cloned in pPM1
using NcoI and XbaI restriction sites leading to plasmid pFR10
(gpdG*). The C17G substitution of GpdD was introduced by site
directed mutagenesis amplifying by PCR using primers 6056 and
6057 and cloning NcoI/XbaI in pPM1 leading to plasmid pFR8.
Table 1. Bacterial strains used in this study.
Bacterial strains Description or genotype Reference or source
E. coli
S17-1 hsdR17 recA1 RP4-2-tet::Mu1kan::Tn7; Sm
r [34]
C. canimorsus
Cc5 Human fatal septicemia after dog bite 1995 [12]
Cc5DsiaC Replacement of Ccan_00790 by ermF;E m
r [13]
Cc5DPUL5 Replacement of Ccan_08700, Ccan_08710, Ccan_08720, Ccan_08730 by ermF :E m
r Manfredi et al., submitted
Cc5DgpdC Replacement of Ccan_08700 by ermF using primers 5073, 5074, 5075, 5083; Em
r This study
Cc5D gpdD Replacement of Ccan_08710 by ermF using primers 4850, 4851, 4854, 4855; Em
r This study
Cc5DgpdG Replacement of Ccan_08720 by ermF using primers 5001, 5002, 5005, 5006; Em
r This study
Cc5DgpdE Replacement of Ccan_08730 by ermF using primers 5951, 5952, 5953, 5954; Em
r This study
Cc5DgpdF Replacement of Ccan_08740 by ermF using primers 5955, 5956, 5957, 5958; Em
r This study
doi:10.1371/journal.ppat.1002118.t001
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mutagenesis amplifying by PCR using primers 6054 and 6055 and
cloning NcoI/XbaI in pPM1 leading to plasmid pFR9.
The C17Y substitution of SiaC was introduced by site directed
mutagenesis amplifying by inverse PCR using primers 5045 and
5046 using as pMM52 as template leading to plasmid pMM121.1.
C-terminal His-Strep double tagged gpdC was amplified by two-
step overlapping PCR using primers 5081, 5467 and 5530 and
cloned in pMM47.A using SalI and SpeI restriction sites leading to
plasmid pPM3.
Fetuin deglycosylation analyses and lectin stainings
Bacteria were collected from blood agar plates and resuspended
in PBS at OD600=1. 100 ml of bacterial suspensions were then
incubated with 100 ml of a fetal calf serum fetuin (Sigma F2379)
solution (0.1 g.l
21) for 120 minutes at 37uC. As negative control,
Table 2. Oligonucleotides used in this study.
Ref. Name Sequence 59-39 Restriction Gene PCR
5502 ermF-fw CTACGAAGGATGAAATTTTTCAGGGACAAC ermF
5503 ermF-rev AACAGTGCTTTTATCTACTCCGATAGCTTC ermF
5081 PgpdC-fw CGATGTCGACTGAATATGTTGTACATTTGTG SalI
5469 PgpdC-rev CATACCATGGCAATAATAAAATGAATTAG NcoI
5082 gpdC-rev CCACTAGTACCTATAATGAAGCTTTAATTGC SpeI gpdC
5467 gpdC-His-rev TGACTAGTTAATGATGATGATGATGATGAGCACCACCAGCACCACCTAATGAAGCTTTAATTGCAATACC SpeI gpdC
5530 gpdC-Strep-rev TGACTAGTTATTTTTCAAATTGAGGATGTGACCAAGCTCCTCCAGCTCCTCCATGATGATGATGATGATGAGC SpeI gpdC
5001 gpdGKO-1.1-fw CGCTGCAGGATTGTAATACCCATCTTTG PstI gpdG A
5002 gpdGKO-1.2-rev GAGTAGATAAAAGCACTGTTGAGACTTGATAACAAGTAAA gpdG B
5005 gpdGKO-2.1-fw AAAAATTTCATCCTTCGTAGTTACTTTGATAAGTATATTA gpdG C
5006 gpdGKO-2.2-rev CCACTAGTCTGACGCCAAATTAGAGTCA SpeI gpdG D
4850 gpdDKO-1.1-fw CCCTGCAGTTAATAAGAAATGAAAAAATAC PstI gpdD A
4851 gpdDKO-1.2-rev GAGTAGATAAAAGCACTGTTAATACGGTAAGGGACCAAAC gpdD B
4854 gpdDKO-2.1-fw AAAAATTTCATCCTTCGTAGTTCTGAAAATGGGGTAAGCA gpdD C
4855 gpdDKO-2.2-rev CCACTAGTAAGATTATCTTGTATTAGGATTC SpeI gpdD D
5073 gpdCKO-1.1-fw CCCTGCAGACTTATAGCTCTTGCGTGCGGACTTTGG PstI gpdC A
5074 gpdCKO-1.2-rev GAGTAGATAAAAGCACTGTTGCACTTCGTTGAATGTTAATGCCAGCCA gpdC B
5075 gpdCKO-2.1-fw AAAAATTTCATCCTTCGTAGTGAAGGCGGTTCAATGACAGCAGTG gpdC C
5083 gpdCKO-2.2-rev CCACTAGTATTCGGGATCAAAAGGCGCTGACAA SpeI gpdC D
5951 gpdEKO-1.1-fw GGCTGCAGCGGTTACCATCCACAAGAGAAAG PstI gpdE A
5952 gpdEKO-1.2-rev GTTGTCCCTGAAAAATTTCATCCTTCGTAGAATTTACTATTTTTTAGGTAATCTG gpdE B
5953 gpdEKO-2.1-fw GAAGCTATCGGAGTAGATAAAAGCACTGTTGATTTCCTAATGTTGATTTTAATACC gpdE C
5954 gpdEKO-2.2-rev GCACTAGTGGGTGAGACATCAGATACTTG SpeI gpdE D
5955 gpdFKO-1.1-fw GGCTGCAGGTTTGAAGCAGCGGGTACTAATCC PstI gpdF A
5956 gpdFKO-1.2-rev GTTGTCCCTGAAAAATTTCATCCTTCGTAGCCCTACCAGTAATACTGTTGTGAG gpdF B
5957 gpdFKO-2.1-fw GAAGCTATCGGAGTAGATAAAAGCACTGTTGGGAGGAGATCAATATGTTGATATAAATG gpdF C
5958 gpdFKO-2.2-rev GCACTAGTCGGCTTTTTCGAATGAAACGAAC SpeI gpdF D
6133 gpdD-fw CATACCATGGGAAAAAAATACTTTATGATAGGTGCTTTATCTTTAGC NcoI gpdD
6057 gpdD-rev GCTCTAGATTATCTTGTATTAGGATTCACATCCCACC XbaI gpdD
5008 gpdG-fw CATGCCATGGGAAAAAAAAATATTATAAAATGGGG NcoI gpdG
6055 gpdG-rev GCTCTAGACTATTTTTTAGGTAATCTGATAATTAATTGCTC XbaI gpdG
5959 gpdE-fw CATACCATGGGAAAGAAATTACATATCTTATTTGTTATCG NcoI gpdE
5960 gpdE-rev GCTCTAGATTAAAATTCTACTTTGGTATTAAAATC XbaI gpdE
5962 gpdF-fw CATACCATGGGAAAAAAACATATAAAAATTTTATTTCTCACAACAG NcoI gpdF
5963 gpdF-rev GCTCTAGACTAATAAAATTCTAATTCATTTATATCAAC XbaI gpdF
6056 gpdDCys-fw CATACCATGGGAAAAAAATACTTTATGATAGGTGCTTTATCTTTAGCTACAATTTCTGGTACGAAAG NcoI gpdD
6054 gpdGCys-fw CATACCATGGGAAAAAAAAATATTATAAAATGGGGTTTAGCAATACTTATAGGGGTAGCTTCTGTAA NcoI gpdG
6060 gpdG-E/G-fw CCAAAAGATATTGACTGGGGACCTACTGTGGGTAATCATGGAAG gpdG
6061 gpdG-E/G-rev CTTCCATGATTACCCACAGTAGGTCCCCAGTCAATATCTTTTGG gpdG
5045 siaCCys-fw CTTTTGTCGGCTTATGGAAGCCAAAAA siaC
5046 siaCCys-rev TTTTTGGCTTCCATAAGCCGACAAAAG siaC
doi:10.1371/journal.ppat.1002118.t002
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120 minutes at 37uC. Samples were then centrifuged for 5 min at
130006 g, supernatant collected and loaded in a 12% SDS gel.
Samples were analyzed by immunoblotting (Fetuin, Rabbit anti-
Bovine RIA, UCBA699/R1H, ACCURATE CHEMICAL &
SCIENTIFIC CORPORATION) and lectin stainings were
performed with Sambucus nigra lectin (SNA) according to
manufacturer recommendations (DIG Glycan Differentiation
Kit, 11210238001, Roche).
Human IgG deglycosylation analyses and lectin stainings
Bacteria were collected from blood agar plates and resuspended
in PBS at OD600=1. 100 ml of bacterial suspensions were then
incubated with 100 ml of a purified human IgG (Invitrogen, 02-
7102) solution (0.5 g.l
21) for 180 minutes at 37uC. As negative
control, 200 ml of 1:2 diluted IgG solution alone was incubated for
180 minutes at 37uC. Samples were then centrufiged for 5 min at
130006 g, supernatant collected and and loaded in a 12% SDS
gel. Samples were analyzed by Coomassie blue staining,
immunoblotting [Goat Anti-Human IgG (Fc specific)-FITC
antibody, F9512 Sigma] and lectin stainings were performed with
SNA according to manufacturer recommendations (DIG Glycan
Differentiation Kit, 11210238001, Roche).
Fetuin and IgG mass spectrometric analyses
Fetuin (Sigma F2379) and human IgG (Invitrogen, 02-7102)
were reduced with 10 mM TCEP at 37uC for 1 hour and
alkylated with 50 mM iodoacetamide for 15 min at room
temperature. Fetuin and IgG were digested with trypsin at an
enzyme to protein ratio of 1:50 (w/w) at 37uC overnight. The
peptides were desalted on C18 StageTips (Thermo Fisher
Scientific, Reinach, Switzerland) according to the manufacurer’s
recommendations. The fetuin and IgG peptides were analysed on
an LTQ Orbitrap instrument (Thermo Fisher, San Jose ´, CA,
USA) coupled to an Agilent 1200 nano pump according to
(Manfredi et al. submitted).
Outer membrane protein purification
Bacteria were collected from blood agar plates and resuspended
in 3 ml ice cold HEPES 10 mM (pH 7.4) at OD600=1. Bacterial
suspensions were then sonicated on ice until they turned clear and
spun at 156006 g for 2 minutes at 4uC. Supernatants were
transferred and centrifuged again for 30 minutes at 156006ga t
4uC. Pellets were resuspended in 2 ml HEPES 10 mM with 1%
sarcosyl (N-Lauroylsarcosine sodium salt, Sigma) and incubated at
room temperature for 30 minutes. Finally, samples were centri-
fuged at 15600 g for 30 min at 4uC and pellet resuspended in
0.1 ml HEPES. Samples were checked for quality and quantity on
silver stained SDS-PAGE and analysed by MS/MS.
Gpd proteins and sialidase co-purification
Cc5 DgpdC bacteria harbouring plasmid pPM3, expressing a C-
terminal His-Strep double tagged GpdC, or harbouring plasmid
pPM2, expressing GpdC without any tag (Mock), were grown for 2
days at 37uC in the presence of 5% CO2 on sheep blood agar
plates. Bacteria from 6 plates were scraped and lysed in 35 ml of
25 mM Tris-HCl, 150 mM NaCl, 0.2% triton, 1% NP-40%, 1%
sodium deoxycholate, pH 7.6.
For His affinity purification, the lysates were clarified by
centrifugation (10 min at 18500 g at RT) and the supernatant was
diluted 1:2 in PBS, 10 mM Imidazole, in the presence of
proteinase inhibitor (cOmplete, Mini, EDTA-free Protease
Table 3. Plasmids used in this study.
Plasmid Description Reference or source
pMM47.A oriColE1, oripCC7,A p
r ,Cf
r, E. coli - C. canimorsus expression shuttle vector. [33]
pPM1 pMM47.A where the ermF promoter has been replaced by the stronger gpd promoter: 117 bp upstream
of the gpdC ORF start codon were amplified with primers 5081 and 5469 and cloned into pMM47.A using
SalIa n dNcoI restriction sites.
This study
pPM2 Full length gpdC containing its putative promoter region amplified with primers 5081 and 5082 and
cloned into pMM47.A using SalIa n dSpeI restriction sites.
This study
pPM3 Full length gpdC with a C-terminal His-Strep double tag amplified by 2-step overlapping PCR with primers
5081, 5467 and 5530 and cloned into pMM47.A using SalIa n dSpeI restriction sites.
This study
pFR4 Full length gpdD amplified with primers 6133 and 6057 and cloned in pPM1 using NcoIa n dXbaI restriction sites. This study
pFR5 Full length gpdG amplified with primers 5008 and 6055 and cloned in pPM1 using NcoIa n dXbaI restriction sites. This study
pFR6 Full length gpdE amplified with primers 5959 and 5060 and cloned in pPM1 using NcoI and XbaI restriction sites. This study
pFR7 Full length gpdF amplified with primers 5062 and 5063 and cloned in pPM1 using NcoI and XbaI restriction sites. This study
pFR8 Full length gpdD with a C17G point mutation amplified with primers 6056 and 6057 and cloned in pPM1 using
NcoI
and XbaI restriction sites.
This study
pFR9 Full length gpdG with a C21G point mutation amplified with primers 6054 and 6055 and cloned in pPM1 using
NcoIa n dXbaI restriction sites.
This study
pFR10 Full length gpdG with a E205G point mutation amplified by overlapping PCR using primers 5008/6061 and
6060/6055 and cloned in pPM1 using NcoIa n dXbaI restriction sites.
This study
pMM121.1 Full length siaC amplified by inverse PCR using primers 5045+5046 on pMM52 as a template to insert to C17Y
substitution in siaC.
This study
pMM25 oriColE1,K m
r,C f
r.Suicide vector for C. canimorsus. [33]
pMM52 Full length siaC with a C-terminal His tag cloned in pMM47.A using NcoIa n dXbaI restriction sites. [13]
pMM106 oriColE1 ,K m
r ,C f
r , Ery
R , Mutator plasmid for the replacement of siaC by ermF [33]
doi:10.1371/journal.ppat.1002118.t003
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sepharose Fast Flow beads (GE Healthcare) was first coupled to
Ni
2+ according to the manufacturer instructions and then 1.75 ml
of resin was added to the solution and incubated overnight at 4uC
on a rotating wheel. The solution was then loaded into a column
and the resin washed first with 25 column volumes (CV) of high
salt buffer (50 mM Tris, 500 mM NaCl, pH 8) and then with 5
CV of low salt buffer (50 mM Tris, 100 mM NaCl, pH 8).
Proteins were then eluted from the resin with 2 CV of elution
buffer (50 mM Tris, 100 mM NaCl, 350 mM Imidazole, pH 8).
The material eluted from the Ni
2+ column was then diluted 1:2 in
PBS and 1 ml of 50% slurry (0.5 ml CV) Strep-Tactin Superflow
resin (IBA, cat No: 2-1206-002) was added. The solution was then
incubated overnight at 4uC on a rotating wheel. The solution was
then loaded into a column and the flow through reloaded into the
resin 2 more times. The resin was then washed 4 times with 10 CV
of Buffer W (100 mM Tris, 150 mM NaCl, 1 mM EDTA, pH 8)
and proteins eluted in 3 steps with 0.5 ml elution buffer (100 mM
Tris, 150 mM NaCl, 1 mM EDTA, 2.5 mM desthiobiotin, pH 8).
The proteins present in the elution fractions were identified by MS
and immunoblotting, using anti-His for GpdC detection, anti-
GpdG and anti-SiaC .
GpdC-sialidase co-purification was performed exactly as
described above using Cc5 DPUL5 bacteria harbouring pPM3
plasmid or harbouring plasmid pPM2 (Mock). Proteins present in
the elution fractions were identified by immunoblotting with anti-
Strep antibodies to detect GpdC and anti-SiaC.
In vivo radiolabeling with [
3H] palmitate, immuno-
precipitation and fluorography
Bacteria were inoculated to HeLa epithelial cells (ATCC CCL-
2) in complete DMEM at 37uC with 5% CO2 at a moi of 20. 15–
16 h post infection, [9,10-
3H] palmitic acid (48 Ci/mmol; Perkin-
Elmer Life Sciences) was added to a final concentration of 50 mCi/
ml and incubation was continued for 8–9 h, by which time the
bacterial culture had reached approximately 10
8 bacteria/ml as
described elsewhere [13]. Supernatants of 261 ml were collected
without detaching epithelial cells from the wells. Bacteria
corresponding to approximately 2610
8 cfu were then collected
by centrifugation and pellets were combined from 2 ml and stored
at 220uC until they were processed. Pellets were resuspended in
0.1 ml PBS TritonX 1% to lyze bacteria and sialidase was
immuno-precipitated by addition of 10 ml rabbit polyclonal anti-
SiaC for 1 h at RT on a rotating wheel. Protein A agarose slurry
(Sigma) was then added in equal amounts for 30 min under
constant rotation at RT. Samples were then centrifuged at
140006g for 2 min at RT, supernatant was discarded and pellets
were washed with 0.5 ml PBS 0.1% Triton which was repeated 4
times. Captured proteins were eluted by addition of 50 mlL a ¨mmli
buffer (1% SDS, 10% glycerol, 50 mM dithiothreitol, 0.02%
bromophenol blue, 45 mM Tris, pH 6.8) for 5 min at 85uC.
Samples were centrifuged again and supernatant was carefully
separated from the agarose beads and loaded on SDS PAGE gels
using 10% polyacrylamide. After gel electrophoresis, gels were
fixed in 25:65:10 isopropanol:water:acetic acid overnight and
subsequently soaked for 30 min in Amplify (Amersham). Gels were
vacuum dried and exposed to SuperRX autoradiography film
(Fuji) for 13days until desired signal strength was reached.
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